However, this was likely due to the fact that having either HPV-DNA-positive or p16-overexpressing OPSCC was a suboptimal way of defining an HPV+ tumor, since although the two correlated in most cases, there still was a 10–15% discrepancy between the two [69]. This evidence concerns the gene CDKN2A and neoplasm.